新型膜式阻塞器修复体对获得性软腭缺损患者言语、吞咽及生活质量疗效的VELOMEMBRANE随机交叉试验研究方案
VELOMEMBRANE试验为优越性、开放标签、二阶段随机交叉临床试验,计划在法国两家教学医院招募14例肿瘤切除后软腭或腭帆组织缺损、需刚性阻塞器修复的成年患者,随机先后佩戴新型膜式阻塞器与常规刚性阻塞器各1个月,主要比较1个月后言语障碍水平(嗓音障碍指数[VHI]总分),次要比较吞咽障碍指数及欧洲癌症研究与治疗组织(EORTC)健康相关生活质量评分。
要点
- 新型膜式阻塞器为可摘树脂修复体,含刚性延伸部固定牙科橡皮障以重建软腭。
- 主要结局为佩戴1个月后VHI总分所反映的发音相关障碍程度。
- 次要结局为吞咽障碍指数与EORTC健康相关生活质量评分。
核心结论
- 该试验旨在提供高质量证据以记录一种可能大幅改善获得性腭帆功能不全患者管理与生活质量的新医疗器械的效用。
研究设计与样本
- VELOMEMBRANE试验为优越性、开放标签、二阶段随机交叉临床试验。
- 在法国两家教学医院招募肿瘤切除后存在腭帆或腭帆-软腭组织缺损且适合刚性阻塞器修复的成年患者。
- 14名参与者被随机分配以两种顺序先后佩戴两种修复体,每种佩戴1个月。
主要发现
- 原文为研究方案,未报告结局数据。
关键数值与推荐
- 主要结局为发音相关障碍程度,采用嗓音障碍指数(VHI)总分。
- 次要结局为吞咽障碍指数及欧洲癌症研究与治疗组织(EORTC)健康相关生活质量评分。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Soft palate defects created during oral cancer surgery may prevent complete palatal closure and trigger palatopharyngeal insufficiency. One current treatment employs a rigid obturator prosthesis; an extension of acrylic resin at the level of the hard palate ensures surface contact with the remaining musculature. Unfortunately, airflow escape often causes hypernasality, compromises speech intelligibility, and creates swallowing problems (including leakage of food and fluid into the nasal airway). We plan to test a new removable denture featuring a thick dental dam that serves as a membrane obturator. The principal objective of the clinical trial is a comparison of speech handicap levels after 1 month in patients with acquired velar insufficiencies who wear either the new device or a conventional, rigid obturator. The secondary objectives are between-device comparisons of the swallowing handicaps and the health-related qualities of life. METHODS: The VELOMEMBRANE trial is a superiority, open-labeled, two-way, random crossover clinical trial. Adult patients exhibiting velar or palatovelar substance loss after tumor excision and who are indicated for rigid obturator-mediated prosthetic rehabilitation will be recruited in two teaching hospitals in France. Fourteen participants will be randomly allocated to wear both prostheses for 1-month periods in either order. The new membrane obturator is a removable resin prosthesis incorporating a rigid extension that holds a dental dam to restore the soft palate. The primary outcome will be the extent of phonation-related disability (the overall score on the Voice Handicap Index [VHI]). The secondary outcomes will be the Deglutition Handicap Index and health-related quality of life scores of the European Organization for Research and Treatment of Cancer (EORTC). DISCUSSION: High-quality evidence will be provided to document the utility of a new medical device that may greatly improve the management and quality of life of patients with acquired velar insufficiency. TRIAL REGISTRATION: ClinicalTrials.gov NCT04009811 . Registered on 4 July 2019.
引用
- Naveau A, Kret M, Plaire V, et al. Efficacy of a new membrane obturator prosthesis in terms of speech, swallowing, and the quality of life of patients with acquired soft palate defects: study protocol of the VELOMEMBRANE randomized crossover trial. Trials. 2022. PMID: 35303932. doi:10.1186/s13063-022-06163-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。